{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:22:50Z","timestamp":1788672170748,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL-137004"],"award-info":[{"award-number":["HL-137004"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1R01HL175306"],"award-info":[{"award-number":["1R01HL175306"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012569","name":"University of Toledo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.amjcard.2025.06.030","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:47:34Z","timestamp":1751420854000},"page":"50-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Oxylipins are Associated With Poor Right Ventricular to Pulmonary Artery Coupling and Adverse Outcomes in Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"254","author":[{"given":"Alex","family":"Kloster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alborz","family":"Sherafati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Wunderly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Aradhyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareeta","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhatchandra","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-7671","authenticated-orcid":false,"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.amjcard.2025.06.030_bib0001","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjcard.2025.06.030_bib0002","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.amjcard.2025.06.030_bib0003","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.mayocp.2018.05.001","article-title":"HFpEF, a disease of the vasculature: a closer look at the other half","volume":"93","author":"Lyle","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.amjcard.2025.06.030_bib0004","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tcm.2018.08.005","article-title":"Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction","volume":"29","author":"Levine","year":"2019","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.amjcard.2025.06.030_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007840","article-title":"Right heart phenotype in heart failure with preserved ejection fraction","volume":"14","author":"Guazzi","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.amjcard.2025.06.030_bib0006","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jacc.2023.05.010","article-title":"Right ventricular function and pulmonary coupling in patients with heart failure and preserved ejection fraction","volume":"82","author":"Inciardi","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjcard.2025.06.030_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.amjcard.2019.05.024","article-title":"Usefulness of right ventricular to pulmonary circulation coupling as an indicator of risk for recurrent admissions in heart failure with preserved ejection fraction","volume":"124","author":"Santas","year":"2019","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.amjcard.2025.06.030_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009047","article-title":"Validation of the tricuspid annular plane systolic excursion\/systolic pulmonary artery pressure ratio for the assessment of right ventricular-arterial coupling in severe pulmonary hypertension","volume":"12","author":"Tello","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.amjcard.2025.06.030_bib0009","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/CIRCHEARTFAILURE.114.001976","article-title":"Elevated plasma marinobufagenin, an endogenous cardiotonic steroid, is associated with right ventricular dysfunction and nitrative stress in heart failure","volume":"8","author":"Kennedy","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"21","key":"10.1016\/j.amjcard.2025.06.030_bib0010","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: results from the PROMIS-HFpEF study","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.amjcard.2025.06.030_bib0011","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/ehf2.14654","article-title":"An altered plasma lipidome-phenome network characterizes heart failure with preserved ejection fraction","volume":"11","author":"Jovanovic","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.amjcard.2025.06.030_bib0012","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1038\/s41467-023-43363-3","article-title":"Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction","volume":"14","author":"Lau","year":"2023","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.amjcard.2025.06.030_bib0013","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ejhf.664","article-title":"Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction","volume":"19","author":"Ghio","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.amjcard.2025.06.030_bib0014","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/CM9.0000000000002637","article-title":"Right ventricular-arterial uncoupling as an independent prognostic factor in acute heart failure with preserved ejection fraction accompanied with coronary artery disease","volume":"136","author":"Jia","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.amjcard.2025.06.030_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.997403","article-title":"Eicosanoids in inflammation in the blood and the vessel","volume":"13","author":"Yamaguchi","year":"2022","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.amjcard.2025.06.030_bib0016","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.amjcard.2025.06.030_bib0017","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC state-of-the-art review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.amjcard.2025.06.030_bib0018","doi-asserted-by":"crossref","first-page":"H777","DOI":"10.1152\/ajpheart.01087.2008","article-title":"20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells","volume":"296","author":"Dhanasekaran","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.amjcard.2025.06.030_bib0019","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1152\/japplphysiol.00247.2002","article-title":"Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries","volume":"93","author":"Yu","year":"2002","journal-title":"J Appl Physiol"},{"issue":"5","key":"10.1016\/j.amjcard.2025.06.030_bib0020","first-page":"L823","article-title":"Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue","volume":"272","author":"Birks","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.amjcard.2025.06.030_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.716801","article-title":"The functions of cytochrome P450 \u03c9-hydroxylases and the associated eicosanoids in inflammation-related diseases","volume":"12","author":"Ni","year":"2021","journal-title":"Front Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.amjcard.2025.06.030_bib0022","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J Lipid Res"},{"issue":"6 Pt 2","key":"10.1016\/j.amjcard.2025.06.030_bib0023","first-page":"H2197","article-title":"Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo","volume":"271","author":"Lai","year":"1996","journal-title":"Am J Physiol"},{"issue":"18","key":"10.1016\/j.amjcard.2025.06.030_bib0024","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1073\/pnas.0805806106","article-title":"Cardiomyocyte cyclooxygenase-2 influences cardiac rhythm and function","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"10.1016\/j.amjcard.2025.06.030_bib0025","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.cellsig.2008.07.013","article-title":"Role of the prostanoid FP receptor in action potential generation and phenotypic transformation of NRK fibroblasts","volume":"20","author":"Almirza","year":"2008","journal-title":"Cell Signal"},{"issue":"1\u20132","key":"10.1016\/j.amjcard.2025.06.030_bib0026","first-page":"49","article-title":"PGF2alpha-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN, Prostaglandins Other Lipid","volume":"85","author":"Rice","year":"2008","journal-title":"Mediat"},{"issue":"4","key":"10.1016\/j.amjcard.2025.06.030_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00561-2023","article-title":"The association of eicosanoids and eicosanoid-related metabolites with pulmonary hypertension","volume":"62","author":"McNeill","year":"2023","journal-title":"Eur Respir J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492500390X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291492500390X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:09:06Z","timestamp":1762078146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291492500390X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"alternative-id":["S000291492500390X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.06.030","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxylipins are Associated With Poor Right Ventricular to Pulmonary Artery Coupling and Adverse Outcomes in Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2025.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}